secwatch.observer — SEC 8-K summary
======================================

Issuer:     Structure Therapeutics Inc. (GPCR)
CIK:        0001888886
Form:       8-K
Filed at:   2026-06-18T20:05:25+00:00
Accession:  0001104659-26-075720
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Structure Therapeutics shareholders elect directors, ratify auditor, approve say-on-pay at 2026 AGM
--------------------------------------------------------------------------------

- Elected Ted W. Love, Raymond Stevens, Daniel G. Welch as Class III directors with >161M votes for each.
- Ratified Ernst & Young as independent auditor for FY2026: 164.8M for, 20.8K against.
- Advisory vote on executive compensation approved: 158.5M for, 6.2M against, 212.7K abstentions.
- 213.2M ordinary shares outstanding as of record date April 20, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/tm2618249d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075720

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer